Establishment and Clinical Application of Breast Cancer Risk Prediction Model Based on Traditional Chinese Medicine Four Diagnostic Instruments and Ultrasound

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age30-75
SponsorTaizhou Hospital

About this trial

Construct a breast cancer risk prediction model based on traditional Chinese medicine four diagnostic instruments and B-ultrasound images. Ensure that the key evaluation indicators of the model reach a high level through clinical verification, so as to contribute to accurate clinical diagnosis and treatment decision-making.

Eligibility criteria

Qualifiers

Female patients aged between 30 and 75.

Patients who have a mass detected by US examination, need to undergo surgery or needle biopsy, and obtain a definite pathological result.

Patients who have obtained complete identification results of tongue, pulse, face, and constitution through the traditional Chinese medicine four diagnostic instruments.

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Diagnosis of Breast Cancer by Traditional Chinese Medicine Four Examinations
  • Ultrasound diagnosis of breast cancer

Treatment groups

1,500 Participants
are divided into 2 treatment groups

Locations

1
Taizhou Central Hospital (Affiliated Hospital of Taizhou University)318000, TaizhouZhejiang, China

Sponsors and collaborators

Taizhou Hospital

Lead sponsor